ניטרודרם 5 TTS Israel - Tiếng Do Thái - Ministry of Health

ניטרודרם 5 tts

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ניטרודרם 5 TTS Israel - Tiếng Do Thái - Ministry of Health

ניטרודרם 5 tts

novartis pharma services ag - glyceryl trinitrate 25 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ניטרודרם 10 TTS Israel - Tiếng Do Thái - Ministry of Health

ניטרודרם 10 tts

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

ניטרודרם 10 TTS Israel - Tiếng Do Thái - Ministry of Health

ניטרודרם 10 tts

novartis pharma services ag - glyceryl trinitrate 50 mg/patch - patches - glyceryl trinitrate - prophylaxis of angina pectoris.

דפוניט NT 5 Israel - Tiếng Do Thái - Ministry of Health

דפוניט nt 5

glaxo smith kline (israel) ltd - glyceryl trinitrate 18.7 mg - patches - glyceryl trinitrate - prophylaxis of angina pectoris alone or in combination with other anti-anginal therapy.

דפוניט 10 NT Israel - Tiếng Do Thái - Ministry of Health

דפוניט 10 nt

glaxo smith kline (israel) ltd - glyceryl trinitrate 37.4 mg - patches - glyceryl trinitrate - prophylaxis of angina pectoris alone or in combination with other anti-anginal therapy.

אוורל 25 Israel - Tiếng Do Thái - Ministry of Health

אוורל 25

j-c health care ltd - estradiol as hemihydrate 1.6 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

אוורל 75 Israel - Tiếng Do Thái - Ministry of Health

אוורל 75

j-c health care ltd - estradiol as hemihydrate 4.8 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis.in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.